Regulation of the innate immune response in alcoholic liver disease by autophagy
Regulation of the innate immune response in alcoholic liver disease by autophagy
批准号:
9250425
负责人:
Mark J Czaja
金额:
$28.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-15 至 2019-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alcoholic liver disease (ALD) is one of the most common liver diseases in the United States and a major cause of chronic liver failure and mortality. The mechanisms of liver injury in ALD remain unclear and as a result there is no proven therapy for this disease. Critical to the development of ALD is an overactive hepatic innate immune response. Activated resident Kupffer cells and recruited macrophages generate soluble factors that lead to steatosis, hepatocellular injury and fibrosis. Recent findings indicat that alcohol promotes proinflammatory M1 rather than anti-inflammatory M2 macrophage polarization. Our prior investigations have identified novel functions for the lysosomal, degradative pathway of autophagy in the regulation of cellular signaling pathways and lipid metabolism that mediate M1 and M2 macrophage polarization. The objective of this proposal is to delineate mechanisms by which autophagy regulates macrophage polarization and the hepatic injury that occurs as the result of the overactive proinflammatory response in ALD. Preliminary findings demonstrate that steatosis and hepatotoxins inhibit macrophage autophagy, and that alcohol and impaired autophagy act in concert to block M2 macrophage polarization. In addition, we have generated macrophage- specific mouse knockouts of autophagy and shown that they are sensitized to the development of a proinflammatory response and liver injury from lipopolysaccharide. Based on these and other preliminary studies, our central hypothesis is that alcohol impairs macrophage autophagy which promotes proinflammatory macrophage polarization and activation leading to an overactive innate immune response and ALD. We will test this hypothesis in studies contained in three Specific Aims that will delineate the mechanism by which macrophage autophagy is decreased by alcohol, and how this effect alters macrophage polarization and the generation of the hepatic innate immune response. First, we will test the hypothesis that alcohol decreases autophagic function in macrophages by inhibiting AMP-activated protein kinase signaling. Second, we will test the hypothesis that an alcohol-induced defect in autophagy promotes M1 and inhibits M2 macrophage polarization through effects on ER stress and mitochondrial beta-oxidation. Third, we will test the hypothesis that decreased autophagy in macrophages in vivo promotes ALD development by leading to an unrestrained proinflammatory immune response. The objective of these studies is to delineate novel paradigms by which the lysosomal pathway of autophagy regulates the hepatic proinflammatory innate immune response to alcohol. The ultimate goal of these investigations is to better understand the basic cellular mechanisms underlying the development of liver injury from alcohol in order to design new strategies to prevent and treat human ALD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
-
批准号:9913994
-
项目类别:
-
资助金额:$47.1万
-
财政年份:2017
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:9270797
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2016
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:9115457
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2016
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:9321316
-
项目类别:
-
资助金额:$41.21万
-
财政年份:2016
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:8785146
-
项目类别:
-
资助金额:$45.61万
-
财政年份:2014
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:9135052
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2014
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:8923124
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2014
-
负责人:Mark J Czaja
-
依托单位:
Modulation of Acute Liver Injury
-
批准号:7908374
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2009
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:6744719
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7901161
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:8697041
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:8369493
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:8112431
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7020690
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7650197
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:8535718
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7305268
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7488998
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:6459216
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:8881150
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
国内基金
海外基金
登录
查看更多内容
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
Innate-likeB细胞受损介导凋亡细胞的清除障碍在系统性红斑狼疮发病中的作用及机制研究
-
批准号:81860295
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2018
-
负责人:张伟
-
依托单位:
控制肠道病毒71型感染的先天性免疫保护机制及其应用
-
批准号:31270951
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:冷启彬
-
依托单位:
microRNA对机体抗病毒固有免疫应答RIG-I信号途径的调控作用及机制研究
-
批准号:31170826
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2011
-
负责人:侯晋
-
依托单位:
C型凝集素样受体识别在原发性皮肤毛霉病中的作用
-
批准号:81171510
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:李若瑜
-
依托单位:
干扰素刺激基因2',3'环核苷酸磷酸二酯酶(CNP)抗病毒特性的研究
-
批准号:31170853
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:蒋栋
-
依托单位:
转录因子IRF3的泛素和SUMO修饰调节机制及其在抗病毒天然免疫中的功能
-
批准号:31130020
-
项目类别:重点项目
-
资助金额:315.0万元
-
批准年份:2011
-
负责人:舒红兵
-
依托单位:
细胞内受体TLR9、NOD1和NOD2在不可分型流感嗜血杆菌肺组织感染中的作用
-
批准号:30670929
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2006
-
负责人:吴晓虹
-
依托单位: